Oral anticoagulation for prolonging survival in patients with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Oral Anticoagulation for Prolonging Survival in Patients With Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455410/all/Oral_anticoagulation_for_prolonging_survival_in_patients_with_cancer.
Oral anticoagulation for prolonging survival in patients with cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. https://evidence.unboundmedicine.com/evidence/view/EBMG/455410/all/Oral_anticoagulation_for_prolonging_survival_in_patients_with_cancer. Accessed November 8, 2024.
Oral anticoagulation for prolonging survival in patients with cancer. (2024). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455410/all/Oral_anticoagulation_for_prolonging_survival_in_patients_with_cancer
Oral Anticoagulation for Prolonging Survival in Patients With Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2024. [cited 2024 November 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455410/all/Oral_anticoagulation_for_prolonging_survival_in_patients_with_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Oral anticoagulation for prolonging survival in patients with cancer
ID - 455410
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455410/all/Oral_anticoagulation_for_prolonging_survival_in_patients_with_cancer
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -